Our mission is consumer safety. Since our humble beginnings (History), ScanAvert has decreased the risk of
ingested harm, enabled dietary adherence, informed and responsible consumption, responsible prescription
use, and alerted subscribers of product recalls. This last function could not be timelier.
Ask the average consumer and he/she would be unaware that the majority of recalls are voluntary. With the
average recall costing $10 million, how much faith should consumers put in self-regulation? With tariffs and
ingredient prices surging, corporations are hit from all sides to retain a margin of profitability. The
second line of defense, government inspectors, have been winnowed down by attrition, and more recently,
government shutdown. As the old adage “physician heal thyself” imparts, ScanAvert has long maintained that
we are our own primary care physician, empowered to research our symptoms, review our habits and find
plausible explanations or at least be guided toward the right questions to ask medical professionals.
Likewise, the time has come, or really thrust upon us, to protect ourselves and our loved ones from exposure
to harmful products. This data exists but siloed, not in any single comprehensive source. Utilizing AI
tools, ScanAvert has created a resource for consumers and enterprises alike, which methodology will aid in
decreasing harmful exposure, and identify vulnerabilities in the supply chain.
Drawing on 20 years’ experience in the securities industry in regulatory compliance, market analysis, and development of algorithms to detect unusual trading, founder Ellen Badinelli adapted that logic to create a system and method of generating alerts for products that deviated from a dietary adherence or preference, alerting subscribers with detailed incompatibility and suggested compatible substitutes. From 2001, ScanAvert advanced development from stationary environments to cell phones, winning subscriber, industry, and media acclaim for each operational environment along the way. Acclaimed by industry, media, medical professionals and consumers, the ScanAvert app was relied upon by tens of thousands of consumers seeking simple tools to assist their adherence to dietary regimens, responsible prescription use, or avoidance of harmful ingredients, simultaneously affording unrivaled consumer insight, as shown video below. Mining user data, ScanAvert was the first to report on the rise of psychotropic drug use, ahead of the shortage, and reported on the top dietary profiles, top nutritional values, and top drugs, delivering an accurate snapshot of the American population’s health.
While the ScanAvert app is no longer on the mobile storefronts, its IP has been licensed by dietary compatibility stakeholders and its data mined for research. ScanAvert continues its aim since inception, the creation of solutions that safeguard consumers, and which data can be studied to reveal correlation between consumables, prescription, symptom, treatment and disease etiology while detecting potential vulnerabilities within the supply chain, and validating our predictive analytics.
We bring logic and method to the currently available tools that fall short of reliability and accuracy in
harmful product notification. Our AI driven algorithms standardize the data the FDA makes publicly
available, along with other CPG product data we ingest, permitting unique classification and that improves
detection and prompts actionable decisions by agencies, manufacturers and retailers.
For consumers, our app alerts them to a product’s recall in their scanning or query history and enables them
to report a product it suspects caused harm within the same platform. This data is seamlessly forwarded to
the FDA (see Solutions), and can also be forwarded to CPG clients, alerting them to potential issues prior
to an increase in complaints, pre-empting widespread exposure, and hastening containment.
